WCM
CLVS

Weld Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Weld Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-40,156
Closed -$193K – 616
2020
Q4 		$193K Sell
40,156
-3,730
-8% -$18.9K 0.08% 408
2020
Q3 		$256K Buy
43,886
+4,020
+10% +$24.1K 0.1% 319
2020
Q2 		$269K Buy
+39,866
New +$302K 0.11% 309
2019
Q4 		– Sell
-140,523
Closed -$552K – 1016
2019
Q3 		$552K Buy
140,523
+100,872
+254% +$816K 0.1% 348
2019
Q2 		$590K Buy
39,651
+27,694
+232% +$500K 0.11% 336
2019
Q1 		$297K Buy
+11,957
New +$300K 0.05% 513

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Weld Capital Management's CLVS Position: Q1 2021 in Review

Weld Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q1 2021, closing a stake of 40,156 shares — an estimated $193K sold.

Weld Capital Management first reported a position in CLVS in Q1 2019 and held it in 6 quarters. The position peaked at $590K in Q2 2019. 165 funds tracked by Wall St. Rank hold CLVS as of Q1 2021.

  • Weld Capital Management reported no remaining Clovis Oncology, Inc. position as of Q1 2021 after selling out during the quarter.
  • Weld Capital Management sold 40,156 Clovis Oncology, Inc. shares in Q1 2021, an estimated $193K.
  • Weld Capital Management first reported a position in Clovis Oncology, Inc. in Q1 2019 and held it in 6 quarters.
  • Weld Capital Management's Clovis Oncology, Inc. position peaked at $590K in Q2 2019.
  • 165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2021.

Based on Weld Capital Management's 13F filing for Q1 2021, filed 17 May 2021.